Catalyst Wire Dossier Catalyst Wire Dossier

Epeleuton

Epeleuton · Afimmune
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Epeleuton, covering 2022-04-21 to 2025-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease [Phase 2]

See pricing